Linked Data API

Show Search Form

Search Results

1134036
unstar this property registered interest false more like this
star this property date less than 2019-06-24more like thismore than 2019-06-24
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading NHS: Drugs remove filter
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the availablity of (a) critical and (b) short shelf-life medicines in the event of the UK leaving the EU without a deal. more like this
star this property tabling member constituency Coatbridge, Chryston and Bellshill remove filter
star this property tabling member printed
Hugh Gaffney more like this
star this property uin 268516 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2019-07-02more like thismore than 2019-07-02
star this property answer text <p>The Government fully understands that maintaining access to all medicines and medical products, including critical medicines and short shelf-life products, is vitally important to millions of people in this country. Ensuring unhindered supply of these products remains the Government’s top priority.</p><p> </p><p>As in preparation for 29 March and 12 April, our ‘no deal’ EU Exit contingency plans for 31 October will cover the NHS, social care and the independent sector and covers all medicines, medical devices and clinical consumables, supplies for clinical trials, vaccines and countermeasures, and organs and tissues for transplants.</p><p>The Department has continued to work closely with the Devolved Administrations, industry trade bodies and suppliers, the NHS and other key stakeholders. Prior to 29 March, the Department analysed the supply chains of 12,300 medicines, close to half a million product lines of medical devices and clinical consumables, vaccines used in national and local programmes, and essential non-clinical goods on which the health and care system relies. These analyses and assessments have been updated where necessary and will continue to be refined while a ‘no deal’ EU Exit remains a possibility. This work has informed our plans.</p><p>We are asking suppliers to analyse their supply chains and to make alternative plans if they anticipate disruption, including rerouting to alternative ports or using airfreight where necessary. Our contingency measures aim to support industry-led measures and, where required, act as a ‘last resort’ to be used only when a supplier’s alternative arrangements encounter difficulties, to ensure uninterrupted supply.</p><p>In the case of medicines that cannot be stockpiled because, for example, they have short shelf-lives, such as medical radioisotopes, we are working closely with suppliers to make alternative arrangements using airfreight.</p><p>Further details can be found at the following link:</p><p><a href="https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans" target="_blank">https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans</a></p><p>While we never give guarantees, we are confident that, if everyone – including suppliers, freight companies, international partners and the health and care system – does what they need to do, the supply of medicines and medical products should be uninterrupted in the event of a no-deal EU Exit.</p>
star this property answering member constituency Wimbledon more like this
unstar this property answering member printed Stephen Hammond more like this
star this property question first answered
less than 2019-07-02T11:33:39.527Zmore like thismore than 2019-07-02T11:33:39.527Z
star this property answering member
1585
unstar this property label Biography information for Stephen Hammond more like this
star this property tabling member
4614
star this property label Biography information for Hugh Gaffney more like this
1138920
unstar this property registered interest false more like this
star this property date less than 2019-07-15more like thismore than 2019-07-15
star this property answering body
Scotland Office more like this
star this property answering dept id 2 more like this
star this property answering dept short name Scotland more like this
star this property answering dept sort name Scotland more like this
star this property hansard heading NHS: Drugs remove filter
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Scotland, what recent discussions he has had with the Secretary of State for Health and Social Care on the supply of medicine to Scotland in the event that the UK leaves the EU without an agreement. more like this
star this property tabling member constituency Coatbridge, Chryston and Bellshill remove filter
star this property tabling member printed
Hugh Gaffney more like this
star this property uin 277259 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2019-07-23more like thismore than 2019-07-23
star this property answer text <p>While the Government believes that leaving the EU with a deal is the best outcome, leaving without a deal remains the legal default at the end of the extension period on 31 October 2019. As a responsible Government, we have been preparing to minimise any disruption in the event of a no-deal scenario and are continuing with these preparations.</p><p> </p><p>The supply of critical ‘category 1’ goods, including medicines and medical products, remains an essential element of the Government’s no-deal contingency planning. The Department of Health and Social Care is working with the Devolved Administrations to support the continuity of medical supplies and medicines for the whole of the UK, and will continue to engage with devolved administration officials and Ministers to prepare for a potential ‘no-deal’ on 31 October. The Government has also set out in a Written Ministerial Statement an update on its preparations for a no-deal scenario on 26 June 2019 (<a href="https://www.parliament.uk/business/publications/written-questions-answers-statements/written-statement/Commons/2019-06-26/HCWS1661/" target="_blank">HCWS1661</a>).</p><p> </p><p> </p><p> </p>
star this property answering member constituency Dumfriesshire, Clydesdale and Tweeddale more like this
unstar this property answering member printed David Mundell more like this
star this property question first answered
less than 2019-07-23T11:39:43.463Zmore like thismore than 2019-07-23T11:39:43.463Z
star this property answering member
1512
unstar this property label Biography information for David Mundell more like this
star this property tabling member
4614
star this property label Biography information for Hugh Gaffney more like this